{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:32:36Z","timestamp":1787956356228,"version":"build-2784847793"},"reference-count":79,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.neuropharm.2013.04.039","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T07:50:09Z","timestamp":1367567409000},"page":"179-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Assessment of subjective cognitive and emotional effects of antipsychotic drugs. Effect by defect?"],"prefix":"10.1016","volume":"72","author":[{"given":"Steffen","family":"Moritz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Andreou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Klingberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Thoering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten J.V.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.04.039_bib78","unstructured":"Andreou, C., Moritz, S., Veith, K., Veckenstedt, R., Naber, D. Dopaminergic modulation of probabilistic reasoning and overconfidence in errors: a double-blind study. Schizophrenia Bulletin, in press."},{"key":"10.1016\/j.neuropharm.2013.04.039_bib1","first-page":"123","article-title":"Patients subjective experiences on antipsychotic medications: implications for outcome and quality of life","volume":"10","author":"Awad","year":"1995","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.tics.2006.03.004","article-title":"Explaining delusions: a cognitive perspective","volume":"10","author":"Bell","year":"2006","journal-title":"Trends in Cognitive Sciences"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1192\/bjp.131.2.222b","article-title":"Haloperidol in normals","volume":"131","author":"Belmaker","year":"1977","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-0447.1994.tb01487.x","article-title":"A\u00a0self-report insight scale for psychosis: reliability, validity and sensitivity to change","volume":"89","author":"Birchwood","year":"1994","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib5","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1017\/S0033291708004650","article-title":"The role of metacognitive beliefs in determining the impact of anomalous experiences: a comparison of help-seeking and non-help-seeking groups of people experiencing psychotic-like anomalies","volume":"39","author":"Brett","year":"2009","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.psc.2007.04.002","article-title":"Antipsychotic medication adherence in schizophrenia","volume":"30","author":"Byerly","year":"2007","journal-title":"Psychiatric Clinics of North America"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib7","first-page":"323","article-title":"Psychometric properties of the Spanish validation of the insight scale","volume":"36","author":"Camprubi","year":"2008","journal-title":"Actas Espanolas De Psiquiatria"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4088\/JCP.v65n1008","article-title":"Computer-assisted self-assessment in persons with severe mental illness","volume":"65","author":"Chinman","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.schres.2006.12.010","article-title":"Social cognition and interaction training (SLIT) for inpatients with schizophrenia spectrum disorders: preliminary findings","volume":"91","author":"Combs","year":"2007","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/070674370404900503","article-title":"Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications","volume":"49","author":"de Haan","year":"2004","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib11","first-page":"112","article-title":"Utilisation en therapeutique psychiatrique d' une derivee d'hibernotherapie","volume":"110","author":"Delay","year":"1952","journal-title":"Annales M\u00e9dico-Psychologiques"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1176\/appi.ajp.159.1.103","article-title":"Antipsychotic medication adherence: is there a difference between typical and atypical agents?","volume":"159","author":"Dolder","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/jhmas\/jrl044","article-title":"Performing a cure for schizophrenia: insulin coma therapy on the wards","volume":"62","author":"Doroshow","year":"2007","journal-title":"Journal of the History of Medicine and Allied Sciences"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00006123-200103000-00041","article-title":"Psychosurgery: a historical overview","volume":"48","author":"Feldman","year":"2001","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1475-2832-3-4","article-title":"Off-label indications for atypical antipsychotics: a systematic review","volume":"3","author":"Fountoulakis","year":"2004","journal-title":"Annals of General Hospital Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cpr.2006.10.004","article-title":"Suspicious minds: the psychology of persecutory delusions","volume":"27","author":"Freeman","year":"2007","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib79","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005053-199104000-00003","article-title":"Reasoning in deluded schizophrenic and paranoid patients. Biases in performance on a probabilistic inference task","volume":"179","author":"Garety","year":"1991","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1037\/0033-2909.103.2.265","article-title":"Relation of sample-size to the stability of component patterns","volume":"103","author":"Guadagnoli","year":"1988","journal-title":"Psychological Bulletin"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.paid.2007.08.014","article-title":"A\u00a0message in the medium? Assessing the reliability of psychopathology e-questionnaires","volume":"44","author":"Jones","year":"2008","journal-title":"Personality and Individual Differences"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib19","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","article-title":"Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia","volume":"160","author":"Kapur","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.schres.2005.01.003","article-title":"From dopamine to salience to psychosis \u2013 linking biology, pharmacology and phenomenology of psychosis","volume":"79","author":"Kapur","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0006-3223(01)01251-3","article-title":"Dopamine D-2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient","volume":"50","author":"Kapur","year":"2001","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial","volume":"64","author":"Keefe","year":"2007","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib24","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1176\/appi.ajp.161.6.985","article-title":"Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol","volume":"161","author":"Keefe","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/oxfordjournals.schbul.a033374","article-title":"The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis","volume":"25","author":"Keefe","year":"1999","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.psychres.2007.07.027","article-title":"Collaboration in outpatient antipsychotic drug treatment: analysis of potentially influencing factors","volume":"161","author":"Klingberg","year":"2008","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1600-0447.2009.01479.x","article-title":"Evaluation of a cognitive behaviourally oriented service for relapse prevention in schizophrenia","volume":"121","author":"Klingberg","year":"2010","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-11-123","article-title":"Cognitive behavioural therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: the POSITIVE Study, a multicenter, prospective, single-blind, randomised controlled clinical trial","volume":"11","author":"Klingberg","year":"2010","journal-title":"Trials"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0447.2005.00741.x","article-title":"Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population","volume":"114","author":"Konings","year":"2006","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib30","first-page":"13","article-title":"L'hibernation artificielle par moyenes pharmacodynamiques et physiques","volume":"59","author":"Laborit","year":"1951","journal-title":"Presse Medicale"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/026988119300700412","article-title":"Neuroleptic-induced deficit syndrome \u2013 old problem, new challenge","volume":"7","author":"Lader","year":"1993","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib32","series-title":"Current Schizophrenia","author":"Lambert","year":"2009"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.mp.4002136","article-title":"How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials","volume":"14","author":"Leucht","year":"2009","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib34","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1026\/0033-3042.59.4.217","article-title":"Effects of cognitive interventions for schizophrenia: a meta-analysis","volume":"59","author":"Lincoln","year":"2008","journal-title":"Psychologische Rundschau"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.schres.2007.07.022","article-title":"Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: a meta-analysis","volume":"96","author":"Lincoln","year":"2007","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib37","doi-asserted-by":"crossref","DOI":"10.1167\/11.2.15","article-title":"Dopaminergic stimulation enhances confidence and accuracy in seeing rapidly presented words","author":"Lou","year":"2011","journal-title":"Journal of Vision"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib38","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.biopsych.2004.01.027","article-title":"A\u00a0meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book","volume":"55","author":"Mishara","year":"2004","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.schres.2006.07.013","article-title":"The selective effect of antipsychotics on the different dimensions of the experience of psychosis in schizophrenia spectrum disorders","volume":"88","author":"Mizrahi","year":"2006","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0447.2009.01356.x","article-title":"The subjective experience of taking antipsychotic medication: a content analysis of Internet data","volume":"120","author":"Moncrieff","year":"2009","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbs005","article-title":"Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis","author":"Moritz","year":"2012","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib42","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1017\/S1355617704104153","article-title":"Memory and attention performance in psychiatric patients: lack of correspondence between clinician-rated and patient-rated functioning with neuropsychological test results","volume":"10","author":"Moritz","year":"2004","journal-title":"Journal of the International Neuropsychological Society"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib43","article-title":"Inversion of the \u201cunrealistic optimism\u201d bias contributes to over-estimation of threat in obsessive-compulsive disorder","author":"Moritz","year":"2013","journal-title":"Behavioral and Cognitive Psychotherapy"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.schres.2008.04.007","article-title":"Differences and similarities in the sensory and cognitive signatures of voice-hearing, intrusions and thoughts","volume":"102","author":"Moritz","year":"2008","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib45","first-page":"1","article-title":"Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients","volume":"1","author":"Moritz","year":"2009","journal-title":"Medical Illness"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib46","doi-asserted-by":"crossref","unstructured":"Moritz, S., Van Quaquebeke, N., Lincoln, T.M., K\u00f6ther, U., Andreou, C., 2013. Can we trust the Internet to measure psychotic symptoms? We should be cautious but not paranoid, submitted for publication.","DOI":"10.1155\/2013\/457010"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib47","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1017\/S0033291710002618","article-title":"Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms","volume":"41","author":"Moritz","year":"2011","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib48","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/YCO.0b013e32833d16a8","article-title":"Detecting and defusing cognitive traps: metacognitive intervention in schizophrenia","volume":"23","author":"Moritz","year":"2010","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib49","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1017\/S0033291707002553","article-title":"Memory and metamemory in schizophrenia: a liberal acceptance account of psychosis","volume":"38","author":"Moritz","year":"2008","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S0033291702006852","article-title":"Source monitoring and memory confidence in schizophrenia","volume":"33","author":"Moritz","year":"2003","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib51","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1017\/S0033291711001899","article-title":"Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial","volume":"42","author":"Morrison","year":"2012","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib52","first-page":"240","article-title":"Subjective well-being under neuroleptic treatment with olanzapine versus clozapine: first results from a double-blind clinical trial using the SWN self-rating scale","volume":"49","author":"Naber","year":"2001","journal-title":"Schizophrenia Research"},{"issue":"Suppl.","key":"10.1016\/j.neuropharm.2013.04.039_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1359786806071248","article-title":"Improving patient outcomes in schizophrenia: achieving remission","volume":"20","author":"Nasrallah","year":"2006","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib54","series-title":"Nebenwirkungen der Verhaltenstherapie \u2013 Vergleich zwischen einer Online-Studie und Patienten einer Hochschulambulanz","author":"Nestoriuc","year":"2011"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib55","series-title":"Dimensionen des Verhaltens. Eine Einf\u00fchrung in die Methodik und die Ergebnisse faktorenanalytischer psychologischer Forschung","author":"Pawlik","year":"1976"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib56","first-page":"CD000088","article-title":"Family intervention for schizophrenia","volume":"12","author":"Pharoah","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib57","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.2196\/jmir.6.3.e29","article-title":"Internet versus mailed questionnaires: a randomized comparison","volume":"6","author":"Ritter","year":"2004","journal-title":"Journal of Medical Internet Research"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/109493103321167983","article-title":"The use of the internet in psychological research: comparison of online and offline questionnaires","volume":"6","author":"Riva","year":"2003","journal-title":"CyberPsychology & Behavior"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib59","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.psychres.2008.02.007","article-title":"Social cognition and interaction training (SCIT) for outpatients with schizophrenia: a preliminary study","volume":"166","author":"Roberts","year":"2009","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib60","series-title":"Kaplan and Sadock's Synopsis of Psychiatry","author":"Sadock","year":"2003"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib61","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.schres.2006.03.033","article-title":"Impact of haloperidol, a dopamine D-2 antagonist, on cognition and mood","volume":"85","author":"Saeedi","year":"2006","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib62","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.eurpsy.2007.06.005","article-title":"Symptomatic remission and social\/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study","volume":"22","author":"San","year":"2007","journal-title":"European Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/08039488.2011.577188","article-title":"Cognitive behavior therapy for schizophrenia: a meta-analytical review of randomized controlled trials","volume":"65","author":"Sarin","year":"2011","journal-title":"Nordic Journal of Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib64","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/cap.2005.15.249","article-title":"Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics","volume":"15","author":"Schimmelmann","year":"2005","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1037\/a0025297","article-title":"Jumping to conclusions, a lack of belief flexibility and delusional conviction in psychosis: a longitudinal investigation of the structure, frequency, and relatedness of reasoning biases","volume":"121","author":"So","year":"2012","journal-title":"Journal of Abnormal Psychology"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib66","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/PSY.0b013e3181e7cca6","article-title":"Do antipsychotics improve reasoning biases? A review","volume":"72","author":"So","year":"2010","journal-title":"Psychosomatic Medicine"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib67","series-title":"Psychopharmacology of Antipsychotics","author":"Stahl","year":"1999"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib68","series-title":"The Maudsley Prescribing Guidelines","author":"Taylor","year":"2009"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib69","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1093\/schbul\/sbl027","article-title":"A\u00a0neuropsychiatric model of biological and psychological processes in the remission of delusions and auditory hallucinations","volume":"32","author":"van der Gaag","year":"2006","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib70","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-003-1648-y","article-title":"Neuroleptic dysphoria: towards a new synthesis","volume":"171","author":"Voruganti","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib71","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0893-133X(01)00263-9","article-title":"Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dysphoric responses and striatal D-2 binding ratios on SPECT imaging","volume":"25","author":"Voruganti","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib72","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/YCO.0b013e3282f52851","article-title":"New generation antipsychotic drugs and compliance behaviour","volume":"21","author":"Voruganti","year":"2008","journal-title":"Current Opinions in Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib73","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jbtep.2011.03.001","article-title":"Targeting reasoning biases in delusions: a pilot study of the Maudsley Review Training Programme for individuals with persistent, high conviction delusions","volume":"42","author":"Waller","year":"2011","journal-title":"Journal of Behavior Therapy and Experimental Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib74","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/schbul\/sbm013","article-title":"A\u00a0bias against disconfirmatory evidence is associated with delusion proneness in a nonclinical sample","volume":"33","author":"Woodward","year":"2007","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib75","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/13803390590949511","article-title":"The contribution of a cognitive bias against disconfirmatory evidence (BADE) to delusions in schizophrenia","volume":"28","author":"Woodward","year":"2006","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib76","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/13546800802099033","article-title":"Belief inflexibility in schizophrenia","volume":"13","author":"Woodward","year":"2008","journal-title":"Cognitive Neuropsychiatry"},{"key":"10.1016\/j.neuropharm.2013.04.039_bib77","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/schbul\/sbm114","article-title":"Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor","volume":"34","author":"Wykes","year":"2008","journal-title":"Schizophrenia Bulletin"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813001858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813001858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T10:22:16Z","timestamp":1563013336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813001858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":79,"alternative-id":["S0028390813001858"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.04.039","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of subjective cognitive and emotional effects of antipsychotic drugs. Effect by defect?","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.04.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}